ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in BHC — Bausch Health Companies Inc.
CIK 1164508
BOSTON, MA
Position in BHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,944,283
-$4,509,888 QoQ
Shares Held
394,378
-67.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 220 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. BHC ranks #22 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in BHC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,944,283 | 394,378 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,454,171 | 1,195,217 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $18,929,402 | 2,723,655 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,326,061 | 205,591 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,721,273 | 1,759,951 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $27,977,742 | 4,324,226 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $38,452,591 | 4,770,793 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $26,604,439 | 3,260,348 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,541,404 | 4,238,365 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $44,149,578 | 4,161,129 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,431,400 | 677,232 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,349,534 | 1,380,722 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $4,574,038 | 728,350 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,177,837 | 1,186,914 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $38,301,983 | 4,581,577 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,350,767 | 540,515 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,469,389 | 125,657 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $278,720 | 13,400 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,504,272 | 96,800 | Shares | Defined | 2020-11-12 | |
| 2020-03-31 | $14,904,164 | 961,559 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||